Spyre Therapeutics, Inc.

Report date
6/30/2023
Quarter
2023 Q2
Filed
5/14/2024
Shares
558,650
Value ($000)
252
Weight
0.0%
2019 Q4 - 2023 Q2 (13 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).